Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. - Wikidata - awgldk - TriplyDB

Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

http://www.wikidata.org/entity/Q44480885

about

Recent developments and innovations in gastric cancer Mutations of mitochondrial 12S rRNA in gastric carcinoma and their significance The prognostic significance of apoptosis-related biological markers in Chinese gastric cancer patients.HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions.Pathogenetic mechanisms in gastric cancer.Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA.Genomic and genetic alterations influence the progression of gastric cancer.Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes--a systematic review.Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma.Immunohistochemical expression and significance of NM23 suppressor protein in primary gastric adenocarcinoma Protein signatures for classification and prognosis of gastric cancer a signaling pathway-based approach.Correlations of Human Epithelial Growth Factor Receptor 2 Overexpression with MUC2, MUC5AC, MUC6, p53, and Clinicopathological Characteristics in Gastric Cancer Patients with Curative Resection.Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients.Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer.Elevated level of spindle checkprotein MAD2 correlates with cellular mitotic arrest, but not with aneuploidy and clinicopathological characteristics in gastric cancer.A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients.Significance of genetic abnormalities of p53 protein in Slovenian patients with gastric carcinoma.Prognostic value and clinicopathological significance of proliferating cell nuclear antigen expression in gastric cancer: a systematic review and meta-analysis Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer.ARHGAP10, downregulated in ovarian cancer, suppresses tumorigenicity of ovarian cancer cells.p53 status correlates with the risk of progression in stage T1 bladder cancer: a meta-analysis Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes.Epidemiologic Study of Human Epidermal Growth Factor Receptor 2 Expression in Advanced/Metastatic Gastric Cancer: an Assessment of Human Epidermal Growth Factor Receptor 2 Status in Tumor Tissue Samples of Gastric and Gastro-Esophageal Junction Canc Role of human epidermal growth factor receptor 2 in gastric cancer: biological and pharmacological aspects.Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma.Cooperate concept of metastasis: site-specific requirement of activated differentiation and dynamic deterioration.An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis.Sustained delivery of siRNA/PEI complex from in situ forming hydrogels potently inhibits the proliferation of gastric cancer rAd-p53 enhances the sensitivity of human gastric cancer cells to chemotherapy.Meta-Analysis of the Relationship between NM23 Expression to Gastric Cancer Risk and Clinical Features.CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination.Prognostic significance of HER2/neu expression in gastric cancer.Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer.Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series.Relation between transforming growth factor-β1 expression, its receptor and clinicopathological factors and survival in HER2-negative gastric cancers.

P2860

Q26751327-196A090D-5621-4DE6-B991-0AF0EE276A33 Q33210189-C1E91C25-F929-4DB4-A7FD-2FBD45C4B8B6 Q34117864-DB48DCF5-642C-4EB4-BFB2-599C432988A7 Q34223664-9EA2BE6F-3603-4F14-9963-53974E934100 Q34324291-FE23F967-2BBF-4095-BC24-9EFB4264A5C7 Q34326627-9A55D24C-C32C-4961-9C3B-BBDB4EE542A0 Q34382499-5F342A9C-3246-4458-9A44-05B485F4F708 Q34497423-E7EA4EF9-F2A4-46E6-8A9C-222EE671B3E6 Q34631121-22B4FCEC-83F7-40C1-AACF-B17099C65A51 Q34756800-560DB0E1-7378-4635-8C28-09CE793CC756 Q35099782-93CE17ED-5CA9-4897-A1D8-18F94D351FC9 Q35235854-53B5893C-9812-45C8-92A2-DF6BD2E7FC9A Q35594687-7C7967D2-5972-443B-BC4C-50BBB863F771 Q35642359-2A6A9E66-7349-429D-850D-D8786C267B71 Q35768487-A55D66F0-5DAE-46CC-A710-A5BC50E6663D Q36066030-7B024B80-D178-4C06-85DE-A1EF37B72446 Q36085663-27B8F81C-F101-429F-9B2B-BA66EC18C358 Q36148016-58F1B9AD-E0F4-4717-8230-821C8E903944 Q36264339-B987D3F8-FF4C-473D-A852-C8008A6548E2 Q36410392-393C574C-5FB9-4DA0-A895-512C14795C0B Q36648866-ABB9244C-50D8-401F-9A1A-168EE78A923A Q36774904-B295868E-BECF-4305-B60C-F2FFC520FE2B Q36853654-EFCA972D-A983-4044-84C8-45AE8E47184D Q36950483-F676162C-24AE-4F31-88B7-9CF52F00636A Q36999892-ECB1481F-EF61-4330-9BFC-0730E70CCD5D Q37454494-EE04EAFB-BD9E-4EDD-B8EF-3CD7D8064BC2 Q37607824-298793A8-D20A-4D1C-BDC8-3A18C4725D0A Q37717190-FA0517C5-4B59-4277-A62D-7A774018BC30 Q37724647-380AE8FF-ED21-4BFE-840D-F3183C237739 Q37941807-43D0ED26-5361-4BC9-807E-96B977F4B4EF Q37995971-87B57628-9ECB-4842-BCB6-2C2485CF0073 Q38691748-D3E34640-A237-4C13-94D0-3D5B44193A05 Q38782352-F7629A4F-D444-4A1D-AD18-CC7B7A05E79E Q39062896-147E9491-3D60-47BC-8C77-48E2CD153557 Q39236583-BD9FE9F1-C931-4A89-BAAC-70E47870CEA9 Q39243936-981A8EDA-45AE-4C30-8DD0-B9F21E1DDBC3 Q44736229-689A37B1-F454-4B8D-87B7-C334FA97A4D9 Q44826887-25D80EEA-193A-43E1-A791-EAD57947D54A Q47124030-A12490D6-1DDA-4333-B8C5-9C83BCA5350E Q51514006-24BA23AA-BE28-49C5-B392-5F343FC6DED3

P2860

Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

http://www.wikidata.org/entity/Q44480885

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

@en

Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

@nl

type

label

Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

@en

Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

@nl

prefLabel

Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

@en

Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

@nl

P1433

Q44480885-BA69DB41-5439-47FD-BCDA-98251FF03F29

P1476

Q44480885-494D9068-C21D-4808-B590-A0EC0935EA23

P2093

Q44480885-17C89504-77D3-45E0-B6DB-676866FF646F

Q44480885-218749F4-2E78-483F-9EB3-DA4A29D0B3A0

Q44480885-35D617F8-A635-40CD-9D35-3644897E78AB

Q44480885-3C0D6A0D-97E1-4A75-9F1D-71B036EC5695

Q44480885-936858CD-861B-46A6-A68E-AE74DEB5F58E

Q44480885-9F918CDD-E7CC-403F-B9A7-2AB594F4E031

Q44480885-AB552B23-4855-4F81-BDCF-BDD8084B4B41

Q44480885-AE93AE9B-5746-4BEB-98C8-4353BE0A2ECB

Q44480885-E6E6A588-6D01-4FB9-A3B1-CFFB88AE8153

P304

Q44480885-8FFABC23-F463-4765-A6FC-DE8C98AACAD3

P31

Q44480885-0176B044-672E-40E9-8834-ED35B10A7631

P356

Q44480885-C728CE3C-7CE4-4599-8FE3-B64859EB1380

P433

Q44480885-2FABB53D-D2A3-453E-829A-66ACCA5C631D

P478

Q44480885-99A50F5F-F38A-410B-9042-0937624CB83F

P577

Q44480885-16AAA4A2-9B1C-4AE4-A9B4-BE9E50EC3743

P5875

Q44480885-D6757B64-311E-4F45-8D4F-1472F5405AC5

P698

Q44480885-C6DC6913-DA9F-47FE-8265-20E91970AA2C

P356

P1433

Japanese Journal of Clinical Oncology

P1476

Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

@en

P2093

Han-Kwang Yang

http://www.w3.org/2001/XMLSchema#string

Hang Jong Yu

http://www.w3.org/2001/XMLSchema#string

Hyuk-Joon Lee

http://www.w3.org/2001/XMLSchema#string

Jin-Pok Kim

http://www.w3.org/2001/XMLSchema#string

Kuhn Uk Lee

http://www.w3.org/2001/XMLSchema#string

Kuk Jin Choe

http://www.w3.org/2001/XMLSchema#string

Kyu Eun Lee

http://www.w3.org/2001/XMLSchema#string

Woo-Ho Kim

http://www.w3.org/2001/XMLSchema#string

Yoon Ho Kim

http://www.w3.org/2001/XMLSchema#string

P304

173-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JJCO/HYG039

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274446047

http://www.w3.org/2001/XMLSchema#string

P698

12810831

http://www.w3.org/2001/XMLSchema#string